Elisa Roda Selected Research

Pt(O,O'-acac)(gamma-acac)(DMS)

4/2021	[Pt(O,O'-acac)(γ-acac)(DMS)]: Alternative Strategies to Overcome Cisplatin-Induced Side Effects and Resistance in T98G Glioma Cells.
1/2019	Long-term effects after treatment with platinum compounds, cisplatin and [Pt(O,O'-acac)(γ-acac)(DMS)]: Autophagy activation in rat B50 neuroblastoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisa Roda Research Topics

Disease

6	Neoplasms (Cancer) 04/2021 - 01/2019
4	Inflammation (Inflammations) 11/2020 - 04/2012
3	Glioma (Gliomas) 04/2021 - 01/2020
3	Glioblastoma (Glioblastoma Multiforme) 04/2021 - 01/2020
2	Neuroblastoma 04/2021 - 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Frailty 06/2021
1	Alcoholism (Alcohol Abuse) 01/2021
1	Neoplasm Metastasis (Metastasis) 05/2020
1	Breast Neoplasms (Breast Cancer) 05/2020
1	Triple Negative Breast Neoplasms 05/2020
1	Emphysema 01/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2018
1	Respiratory Tract Diseases (Respiratory Tract Disease) 04/2012
1	Gliosis 05/2008
1	Body Weight (Weight, Body) 07/2006

Drug/Important Bio-Agent (IBA)

5	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 07/2006
2	Pt(O,O'-acac)(gamma-acac)(DMS)IBA 04/2021 - 01/2019
2	Platinum Compounds (Compounds, Platinum)IBA 04/2021 - 01/2019
2	PlatinumIBA 01/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
2	ProdrugsIBA 01/2021 - 01/2020
2	Interleukin-8 (Interleukin 8)IBA 01/2021 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 05/2020 - 01/2018
1	hericenone DIBA 06/2021
1	ErgothioneineIBA 06/2021
1	erinacine AIBA 06/2021
1	hericenone CIBA 06/2021
1	AcidsIBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	LigandsIBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 11/2020
1	Ion Pumps (Ion Pump)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	Glutathione PeroxidaseIBA 01/2018
1	ImmunosorbentsIBA 01/2018
1	InterferonsIBA 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	InterleukinsIBA 01/2018
1	Interleukin-4 (Interleukin 4)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Oxidants (Oxidizing Agents)IBA 01/2018
1	Monocyte Chemoattractant ProteinsIBA 01/2018
1	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	EnzymesIBA 01/2018
1	Superoxide DismutaseIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	AntioxidantsIBA 01/2018
1	Cytoskeletal ProteinsIBA 01/2015
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2015
1	Biological ProductsIBA 04/2012
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2012
1	Drinking WaterIBA 05/2008
1	Dihydrotachysterol (AT 10)IBA 07/2006

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2019
3	Drug Therapy (Chemotherapy) 04/2021 - 01/2020
1	Immunomodulation 11/2020
1	Integrative Oncology 05/2020
1	Aftercare (After-Treatment) 01/2019